Treatment.com AI to Present at the 2024 Cantech Letter Conference in Toronto, ON
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) announces its participation in the 2024 Cantech Letter Investment Conference on October 9, 2024 in Toronto, Ontario. CEO Dr. Essam Hamza will deliver an investor presentation at 11:00 AM ET and participate in 1-on-1 meetings with investors. The event will take place at the Arcadian Loft, 8th floor, 401 Bay Street.
Dr. Hamza emphasized the conference's importance, stating, "The healthcare system is at the precipice of substantial modernization and we believe that our proprietary platform can help with reducing its inefficiencies, reducing administration headaches, and ultimately improving patient access and care." Interested parties can contact tara@cantechletter.com to register or schedule 1-on-1 meetings with Treatment.com AI.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) annuncia la sua partecipazione alla Conferenza di Investimento Cantech Letter 2024 il 9 ottobre 2024 a Toronto, Ontario. Il CEO Dr. Essam Hamza presenterà un intervento per gli investitori alle 11:00 AM ET e parteciperà a incontri one-on-one con gli investitori. L'evento si terrà presso l'Arcadian Loft, 8° piano, 401 Bay Street.
Il Dr. Hamza ha sottolineato l'importanza della conferenza, affermando: "Il sistema sanitario è sull'orlo di una sostanziale modernizzazione e crediamo che la nostra piattaforma proprietaria possa contribuire a ridurre le sue inefficienze, alleviare i problemi amministrativi e, in ultima analisi, migliorare l'accesso e le cure per i pazienti." Le parti interessate possono contattare tara@cantechletter.com per registrarsi o organizzare incontri one-on-one con Treatment.com AI.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) anuncia su participación en la Conferencia de Inversión Cantech Letter 2024 el 9 de octubre de 2024 en Toronto, Ontario. El CEO Dr. Essam Hamza dará una presentación para inversores a las 11:00 AM ET y participará en reuniones uno a uno con inversores. El evento se llevará a cabo en el Arcadian Loft, 8° piso, 401 Bay Street.
El Dr. Hamza enfatizó la importancia de la conferencia, afirmando: "El sistema de salud está al borde de una modernización sustancial y creemos que nuestra plataforma propietaria puede ayudar a reducir sus ineficiencias, aliviar los problemas administrativos y, en última instancia, mejorar el acceso y la atención al paciente." Las partes interesadas pueden contactar a tara@cantechletter.com para registrarse o agendar reuniones uno a uno con Treatment.com AI.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF)는 2024년 10월 9일 온타리오주 토론토에서 열리는 2024 Cantech Letter 투자 컨퍼런스에 참여한다고 발표했습니다. CEO Dr. Essam Hamza는 오전 11:00 ET에 투자자 발표를 하고 투자자와의 1:1 미팅에도 참여할 예정입니다. 이번 행사는 Arcadian Loft, 8층, 401 Bay Street에서 개최됩니다.
Hamza 박사는 컨퍼런스의 중요성을 강조하며 "헬스케어 시스템은 상당한 현대화의 기로에 있으며, 우리의 독점 플랫폼이 비효율성을 줄이고 행정적인 골치를 덜어주며 궁극적으로 환자의 접근성과 치료를 개선하는 데 도움이 될 것이라고 믿습니다."라고 말했습니다. 관심 있는 쪽은 tara@cantechletter.com으로 연락하여 등록하거나 Treatment.com AI와의 1:1 미팅을 예약할 수 있습니다.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) annonce sa participation à la Conférence d'Investissement Cantech Letter 2024 le 9 octobre 2024 à Toronto, Ontario. Le PDG Dr. Essam Hamza présentera une intervention pour les investisseurs à 11h00 ET et participera à des réunions individuelles avec les investisseurs. L'événement se déroulera au Arcadian Loft, 8e étage, 401 Bay Street.
Le Dr. Hamza a souligné l'importance de la conférence, en déclarant : "Le système de santé est à un tournant majeur de sa modernisation, et nous croyons que notre plateforme propriétaire peut aider à réduire ses inefficiences, à alléger les maux de tête administratifs et, en fin de compte, à améliorer l'accès et les soins aux patients." Les personnes intéressées peuvent contacter tara@cantechletter.com pour s'inscrire ou planifier des réunions individuelles avec Treatment.com AI.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) gibt bekannt, dass es an der Cantech Letter Investment Conference 2024 am 9. Oktober 2024 in Toronto, Ontario teilnimmt. CEO Dr. Essam Hamza wird um 11:00 Uhr ET eine Investorenpräsentation halten und an persönlichen Gesprächen mit Investoren teilnehmen. Die Veranstaltung findet im Arcadian Loft, 8. Etage, 401 Bay Street statt.
Dr. Hamza betonte die Wichtigkeit der Konferenz und erklärte: "Das Gesundheitssystem steht am Rand einer erheblichen Modernisierung, und wir glauben, dass unsere proprietäre Plattform dazu beitragen kann, seine Ineffizienzen zu reduzieren, administrative Kopfschmerzen zu verringern und letztendlich den Zugang und die Versorgung von Patienten zu verbessern." Interessierte können sich unter tara@cantechletter.com registrieren oder 1:1-Meetings mit Treatment.com AI vereinbaren.
- None.
- None.
Treatment.com AI CEO, Dr. Essam Hamza, is to present live at 11:00 AM ET on Wednesday, October 9, 2024.
VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”), a healthcare tech company focused on transforming patient care with AI-driven Clinical insights, is pleased to announce its participation at the upcoming Cantech Letter Investment Conference on Wednesday, October 9, 2024 in Toronto Ontario. Dr. Essam Hamza, CEO of Treatment.com AI , will be attending the conference, delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors at the conference.
2024 Cantech Letter Conference
Date: Wednesday, October 9, 2024
Time: 11:00 AM Eastern Time in Track 1
Location: Arcadian Loft, 8th floor, 401 Bay Street, Toronto, ON
Contact: tara@cantechletter.com to register
More info: https://www.cantechletter.com/conference/
Dr. Essam Hamza, CEO of Treatment.com AI, commented, "We are looking forward to presenting at Cantech, a great conference providing a timely opportunity to talk to investors, analysts and the investment community. The healthcare system is at the precipice of substantial modernization and we believe that our proprietary platform can help with reducing its inefficiencies, reducing administration headaches, and ultimately improving patient access and care."
Dr. Essam Hamza will also be conducting in-person 1x1 meetings at the conference venue on Wednesday, October 9, 2024. To schedule 1-on-1 investor meetings with Treatment and attend the 2024 Cantech Letter Conference, please contact Tara Whittet at tara@cantechletter.com. 1x1 meetings will be conducted in person at the conference venue: Arcadian Loft, Toronto.
About Cantech Letter Conference
The Cantech Letter Conference, recognized as Canada's foremost technology investment event, provides up and coming technology companies with the unique opportunity to showcase their innovations and growth strategies, and participate in individual 1-on-1 meetings with potential investors and capital markets professionals. The conference serves as a hub for networking, knowledge exchange, and investment opportunities, while also featuring panel discussions with industry experts to offer insights into current trends, challenges, and opportunities within the technology sector.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than ~10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and enables greater consistency in quality of patient support. Treatment’s GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment’s products and services: www.treatment.com or email: info@treatment.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statements
This news release contains forward-looking statements that are based on Treatment.com AI’s expectations, estimates and projections regarding its business and the economic environment in which it operates. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
FAQ
When and where is Treatment.com AI (TREIF) presenting at the 2024 Cantech Letter Conference?
Who will be representing Treatment.com AI (TREIF) at the 2024 Cantech Letter Conference?
How can investors schedule 1-on-1 meetings with Treatment.com AI (TREIF) at the 2024 Cantech Letter Conference?
What is the focus of Treatment.com AI (TREIF) as presented in the announcement?
